logo
Cava makes its debut in Michigan

Cava makes its debut in Michigan

Yahoo22-07-2025
Cava Photo courtesy of Cava
You can find original article here Nrn. Subscribe to our free daily Nrn newsletter.
Cava has opened its first location in Michigan, in the Detroit suburb of Canton, as part of its broader plan to expand across the state.
'We're thrilled to join the Southeast Michigan community and introduce more guests to the bold, vibrant flavors of the Mediterranean,' regional leader Gino Carlin said in a statement. 'Entering the state of Michigan marks our 28th state, and we're eager to welcome more guests in the Midwest and throughout the country to our table to enjoy our Mediterranean cuisine and hospitality.'
The Michigan entry comes on the heels of Cava's debut in Indiana in March and a successful debut in Chicago last year, which chief executive officer Brett Schulman called the company's most successful market opening to date.
The company finished 2024 with 58 net new restaurants for 367 total and is projecting 64 to 68 new units in 2025, including in new markets Detroit and Pittsburgh. It's targeting 1,000 locations by 2032.
Chief financial officer Tricia Tolivar recently told analysts that new restaurants are performing strongly.
'The cohort that opened in Q4 is performing at average weekly sales levels above 2023,' she said. 'We're still early in looking at these restaurants and understanding how they're going to behave, but we feel very confident in our ability to deliver $2.3 million (average unit volumes) in year one with 10% growth driving to $2.5 million and then 8% growth in the following years.'
Cava's first quarter earnings included a 10.8% increase in same-store sales driven by 7.5% traffic growth. During its quarterly earnings call in May, Schulman said "we continued to demonstrate the strength of our category-defining brand, further cementing Mediterranean as the next major cultural cuisine category."
Contact Alicia Kelso at Alicia.Kelso@informa.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stellantis warns of $1.7 billion earnings hit from tariffs
Stellantis warns of $1.7 billion earnings hit from tariffs

CBS News

time2 hours ago

  • CBS News

Stellantis warns of $1.7 billion earnings hit from tariffs

Stellantis, the maker of more than a dozen automotive brands, on Tuesday said that President Trump's tariffs will cost the auto manufacturer 1.5 billion euros, or about $1.7 billion, in 2025. The parent company of brands like Chrysler, Fiat, Jeep and Peugeot announced the projected earnings hit as Mr. Trump clinches deals with U.S. trade partners that include steep tariffs on U.S. imports, ahead of an Aug. 1 deadline. Stellantis said it expects the majority of the hit, about 1.2 billion euros, will come in the second half of 2025. "Stellantis updates its estimate of 2025 net tariff impact to approximately €1.5 billion, of which €0.3 billion was incurred in H1 2025. The Company remains highly engaged with relevant policymakers, while continuing long-term scenario planning," the company said in a statement Tuesday as it reported financial results for the first half of 2025. The automaker acknowledged that Mr. Trump's 25% tariffs on imports of autos and auto parts to the U.S. are hurting its business, particularly in North America. Stellantis builds its Chrysler, Dodge and Jeep brand vehicles in factories in Canada and Mexico, meaning they're subject to the new levies. While Mr. Trump's deal with the EU, calling for 15% tariffs across the board will make BMW and Mercedes-Benz vehicles more expensive for U.S. consumers, according to analysts. Stellantis is largely unaffected by the EU agreement. "Stellantis isn't much affected by the EU/US tariff news — the question for STLA is if the Detroit-3 will want to renegotiate the [U.S.-Mexico-Canada Agreement (USMCA)] tariff after the EU and Japan got a better deal," UBS analysts said in a research note. Other automobile manufacturers, including General Motors, have been bracing for impact from tariffs. GM CEO Mary Barra said the company took a $1.1 billion hit from tariffs in the second quarter, and that the company is taking steps to reduce its tariff exposure by investing in U.S. assembly plants. European automaker Volkswagen also said last week that tariffs cost the company $1.5 billion in the first half of 2025.

TriMas: Q2 Earnings Snapshot
TriMas: Q2 Earnings Snapshot

San Francisco Chronicle​

time3 hours ago

  • San Francisco Chronicle​

TriMas: Q2 Earnings Snapshot

BLOOMFIELD HILLS, Mich. (AP) — BLOOMFIELD HILLS, Mich. (AP) — TriMas Corp. (TRS) on Tuesday reported profit of $16.7 million in its second quarter. The Bloomfield Hills, Michigan-based company said it had net income of 41 cents per share. Earnings, adjusted for one-time gains and costs, were 61 cents per share. The maker of packaging materials, aerospace components and other engineered parts posted revenue of $274.8 million in the period. TriMas expects full-year earnings in the range of $1.95 to $2.10 per share. _____

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

Yahoo

time4 hours ago

  • Yahoo

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store